$$\rightleftharpoonup{xx}$$
$$\longleftharp{xx}$$,
$$\longrightharp{xx}$$,
Cellular senescence is a multifaceted response that can arise from many types of stress, including DNA damage, telomere attrition, and oncogene activation. It leads to a stable arrest of the cell cycle together with increased resistance to apoptosis, driven in part by the induction of anti-apoptotic proteins1,2. Senescence has been linked to improved cell survival in contexts where preservation of tissue integrity is essential, such as repair and maintenance3,4. Beyond its role in tissue homeostasis, senescence also contributes to normal development by shaping embryonic patterning5,6and as a barrier to tumor formation by promoting the clearance of damaged or potentially malignant cells7,8,9. Although senescence can serve beneficial functions, multiple studies have highlighted a contrasting aspect in which senescent cells acquire a pro-inflammatory secretory profile that can disturb local metabolism, damage surrounding tissue, and even support tumor progression10,11,12,13.
Senescence has been detected in diverse cell types across multiple tissues and is often associated with aging, disease, tissue dysfunction, or cancer. In the liver, senescence of hepatic stellate cells has been shown to promote tumor progression by altering metabolic homeostasis through secreted factors14,15. Studies examining hepatocytes16 or whole liver biopsies17 indicate that senescence in these cells can contribute to metabolic comorbidities such as metabolic dysfunction-associated steatotic liver disease and dysfunction-associated steatohepatitis. Furthermore, the relationship between type 2 diabetes and senescence has gained significant attention over the past decade, with evidence linking senescence to diabetes-related complications in pancreatic β-cells, hepatocytes16, and adipocytes18,19,20,21. These findings highlight the importance of accurately identifying senescent cells in metabolic tissues, where their accumulation and heterogeneity contribute to disease progression and therapeutic targeting22.
The signaling and protein expression changes associated with senescence are often cell- and tissue-specific; however, several features are broadly characteristic of senescent cells. One of the most widely used markers is the increased enzymatic activity of β-galactosidase at pH 6.0, referred to as senescence-associated β-galactosidase (SA-β-gal)23. β-galactosidase is a lysosomal hydrolase present in all cells and is normally active at acidic pH (~4.5–5.0), where it contributes to the degradation of glycosylated substrates. The defining feature of SA-β-gal is the retention of β-galactosidase activity under suboptimal pH conditions. In the classical assay, cells are incubated with the synthetic substrate 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside (X-gal) at pH 6.0, where enzymatic activity is reduced in most cells but remains detectable in senescent cells. This leads to the formation of an insoluble blue precipitate that can be visualised microscopically24.
While this assay has been widely adopted, detection of the X-gal precipitate has traditionally relied on brightfield microscopy. Brightfield detection relies on visual identification of blue precipitate and therefore has limited sensitivity for low-level signals and early senescence states. In contrast, reflected light imaging captures the optical density of the X-gal precipitate, enabling quantitative detection across a broader dynamic range. More recently, fluorogenic substrates have been developed to improve sensitivity25. However, these approaches typically measure β-galactosidase activity under conditions that do not preserve the classical pH-dependent definition of SA-β-gal. As a result, they may increase signal intensity but reduce specificity for senescence. In contrast, the inherent opacity of the X-gal precipitate enables its detection using confocal reflected light imaging, providing a more sensitive and quantitative readout while maintaining the original enzymatic definition of SA-β-gal26.
Over the years, additional hallmarks of senescence have been identified, including increased expression of the cyclin-dependent kinase inhibitors P16 and P21, as well as the transcription factor P53, which regulates cell-cycle arrest and other senescence programs27,28,29,30,31,32,33. These advances have led to a more robust definition of senescence, in which cells are typically classified based on the combined presence of multiple markers. In practice, however, these markers are often measured using different modalities: nuclear markers, such as P16 and P21, are typically detected using fluorescence-based techniques, whereas SA-β-gal activity has traditionally been assessed by brightfield microscopy. This separation has limited the ability to evaluate multiple senescence features within the same cell. Reflected light imaging overcomes this limitation by enabling direct integration of SA-β-gal detection with fluorescence-based markers within a single imaging workflow, facilitating a more robust and biologically meaningful assessment of senescence in heterogeneous cell populations.
While Dedic and colleagues address several limitations of traditional SA-β-gal imaging, including improved sensitivity, the use of pH-matched controls for objective thresholding, and compatibility with immunocytochemistry, their reflected-light confocal method was optimized specifically for isolated mature adipocytes26. However, senescence in adipose tissue is not restricted to adipocytes34,35, and additional insight can be gained by examining the stromal vascular fraction (SVF). The SVF comprises preadipocytes, endothelial and fibroblast populations, and diverse immune cells, all of which may undergo senescence and contribute to adipose remodeling, inflammation, and altered metabolic signaling. Characterizing senescence within this heterogeneous compartment is therefore important for linking cell-type-specific processes to tissue-level and systemic outcomes.
Here, we extend reflected light SA-β-gal detection to SVF cells, enabling its application across multiple adipose tissue cell types. By combining this approach with immunocytochemistry, the method enables integrated single-cell analysis of SA-β-gal activity alongside lineage and functional markers in primary human samples.